Literature DB >> 26837611

Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral Sclerosis.

Lauren Tabor1,2, Joy Gaziano3, Stephanie Watts3, Raele Robison4,5, Emily K Plowman4,5.   

Abstract

Although it is known that dysphagia contributes to significant malnutrition, pneumonia, and mortality in amyotrophic lateral sclerosis (ALS), it remains unclear how swallowing impairment impacts quality of life in this vulnerable patient population. The aim of the current study was to (1) delineate swallow-related quality of life (SR-QOL) profiles in individuals with ALS and (2) evaluate relationships between SR-QOL, degree of swallowing impairment, and ALS global disease progression. Eighty-one ALS patients underwent a standardized videofluoroscopic swallow study and completed the swallowing quality of life (SWAL-QOL) instrument and ALS functional rating scale-revised (ALSFRS-R). Penetration Aspiration Scale (PAS) scores were derived by a blinded rater. Correlation analyses and a between groups ANOVA (safe vs. penetrators vs. aspirators) were performed. Mean SWAL-QOL score for this cohort was 75.94 indicating a moderate degree of SR-QOL impairment with fatigue, eating duration, and communication representing the most affected domains. Correlations were revealed between the SWAL-QOL and (1) PAS (r = -0.39, p < 0.001) and (2) ALSFRS-R (r = 0.23, p < 0.05). Mean (SD) SWAL-QOL scores for safe versus penetrator versus aspirator groups were 81.2 (2.3) versus 77 (3.4) versus 58.7 (5.9), respectively, with a main effect observed [F(2,78) = 9.71, p < 0.001]. Post hoc testing revealed lower SWAL-QOL scores for aspirators versus safe swallowers (p < 0.001) and aspirators versus penetrators (p < 0.001). Overall, SR-QOL was moderately reduced in this cohort of ALS patients and profoundly impacted in ALS aspirators and individuals with advanced disease. These findings highlight the importance of early multidisciplinary intervention to not only avoid malnutrition, weight loss, and pulmonary sequelae but also the associated reduced QOL seen in these individuals.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Deglutition; Deglutition disorders; Dysphagia; Quality of life

Mesh:

Year:  2016        PMID: 26837611      PMCID: PMC4871719          DOI: 10.1007/s00455-015-9686-2

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  33 in total

1.  Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life.

Authors:  G Paris; O Martinaud; A Petit; A Cuvelier; D Hannequin; P Roppeneck; E Verin
Journal:  J Oral Rehabil       Date:  2012-12-27       Impact factor: 3.837

2.  Respiratory and nutritional support in amyotrophic lateral sclerosis.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

3.  The relationship between depressive symptoms, quality of life, and swallowing function in head and neck cancer patients 1 year after definitive therapy.

Authors:  Brian M Lin; Heather M Starmer; Christine G Gourin
Journal:  Laryngoscope       Date:  2012-03-29       Impact factor: 3.325

4.  The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity.

Authors:  Colleen A McHorney; Joanne Robbins; Kevin Lomax; John C Rosenbek; Kimberly Chignell; Amy E Kramer; D Earl Bricker
Journal:  Dysphagia       Date:  2002       Impact factor: 3.438

5.  Clinical validity of the SWAL-QOL and SWAL-CARE outcome tools with respect to bolus flow measures.

Authors:  Colleen A McHorney; Bonnie Martin-Harris; JoAnne Robbins; John Rosenbek
Journal:  Dysphagia       Date:  2006-07       Impact factor: 3.438

6.  Impact of dysphagia on quality of life after treatment of head-and-neck cancer.

Authors:  Nam P Nguyen; Cheryl Frank; Candace C Moltz; Paul Vos; Herbert J Smith; Ulf Karlsson; Suresh Dutta; Allan Midyett; Jessica Barloon; Sabah Sallah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

Review 7.  Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis.

Authors:  Peter Kühnlein; Hans-Jürgen Gdynia; Anne-Dorte Sperfeld; Beate Lindner-Pfleghar; Albert Christian Ludolph; Mario Prosiegel; Axel Riecker
Journal:  Nat Clin Pract Neurol       Date:  2008-06-17

Review 8.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 9.  Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis.

Authors:  S T Ngo; F J Steyn; P A McCombe
Journal:  J Neurol Sci       Date:  2014-03-03       Impact factor: 3.181

10.  Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.

Authors:  Sonja Körner; Melanie Hendricks; Katja Kollewe; Antonia Zapf; Reinhard Dengler; Vincenzo Silani; Susanne Petri
Journal:  BMC Neurol       Date:  2013-07-12       Impact factor: 2.474

View more
  31 in total

Review 1.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

2.  To Cough or Not to Cough? Examining the Potential Utility of Cough Testing in the Clinical Evaluation of Swallowing.

Authors:  Stephanie A Watts; Lauren Tabor; Emily K Plowman
Journal:  Curr Phys Med Rehabil Rep       Date:  2016-09-12

3.  The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States.

Authors:  Emily K Plowman; Lauren C Tabor; James Wymer; Gary Pattee
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-04-20       Impact factor: 4.092

4.  Dual delivery of hydrophilic and hydrophobic drugs from chitosan/diatomaceous earth composite membranes.

Authors:  Rita López-Cebral; Guangjia Peng; Lara L Reys; Simone S Silva; Joaquim M Oliveira; Jie Chen; Tiago H Silva; Rui L Reis
Journal:  J Mater Sci Mater Med       Date:  2018-02-02       Impact factor: 3.896

5.  Reduced pharyngeal constriction is associated with impaired swallowing efficiency in Amyotrophic Lateral Sclerosis (ALS).

Authors:  Ashley A Waito; Lauren C Tabor-Gray; Catriona M Steele; Emily K Plowman
Journal:  Neurogastroenterol Motil       Date:  2018-08-20       Impact factor: 3.598

6.  Health-Related Quality of Life and Oropharyngeal Dysphagia: A Systematic Review.

Authors:  Ellie Jones; Renée Speyer; Berit Kertscher; Deborah Denman; Katina Swan; Reinie Cordier
Journal:  Dysphagia       Date:  2017-09-02       Impact factor: 3.438

7.  Dysphagia-related quality of life in oculopharyngeal muscular dystrophy: Psychometric properties of the SWAL-QOL instrument.

Authors:  Sarah Youssof; Carol Romero-Clark; Teddy Warner; Emily Plowman
Journal:  Muscle Nerve       Date:  2017-02-12       Impact factor: 3.217

8.  Oropharyngeal Dysphagia Evaluation Tools in Adults with Solid Malignancies Outside the Head and Neck and Upper GI Tract: A Systematic Review.

Authors:  Ciarán Kenny; Órla Gilheaney; Declan Walsh; Julie Regan
Journal:  Dysphagia       Date:  2018-04-02       Impact factor: 3.438

9.  Shifting Tides Toward a Proactive Patient-Centered Approach in Dysphagia Management of Neurodegenerative Disease.

Authors:  Nicole M Rogus-Pulia; Emily K Plowman
Journal:  Am J Speech Lang Pathol       Date:  2020-07-10       Impact factor: 2.408

10.  Reflexive Airway Sensorimotor Responses in Individuals with Amyotrophic Lateral Sclerosis.

Authors:  Lauren Tabor-Gray; Terrie Vasilopoulos; Karen Wheeler-Hegland; James Wymer; Emily K Plowman
Journal:  Dysphagia       Date:  2020-08-10       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.